Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
Quinazoline derivatives, compositions, and uses related thereto
US10045989B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10045989-B2 |
| Application number | US-201615147531-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 5, 2016 |
| Priority date | May 31, 2012 |
| Publication date | Aug 14, 2018 |
| Grant date | Aug 14, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The disclosure relates to quinazoline derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to inhibitors of NADPH-oxidases (Nox enzymes) and/or myeloperoxidase.
First claim
Opening claim text (preview).
The invention claimed is: 1. A pharmaceutical composition comprising a compound 3-amino-6-fluoro-2-thioxo-2,3-dihydroquinazolin-4(1H)-one or salts thereof. 2. An aqueous biological storage medium comprising a compound of claim 1 . 3. The biological storage medium of claim 2 , further comprising a salt, an amino acid, a saccharide, a vitamin, or adenosine triphosphate.
Assignees
Inventors
Classifications
Drugs for disorders of the nervous system · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
- A61K31/517Primary
ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
Anti-ageing preparations · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10045989B2 cover?
- The disclosure relates to quinazoline derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to inhibitors of NADPH-oxidases (Nox enzymes) and/or myeloperoxidase.
- Who is the assignee on this patent?
- Univ Emory
- What technology area does this patent fall under?
- Primary CPC classification A61K31/517. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).